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I. INTRODUCTION

L
OW endothelial wall shear stress (WSS) promotes the development of early fibroatheromas, which evolution follows an individualized natural history of progression [1] , [2] . In vivo assessment of the local WSS, extent of vascular inflammation, and arterial remodeling response, all responsible for individual plaque evolution, in combination with systemic biomarkers of vascular inflammation, may all together improve risk stratification of individual early atherosclerotic plaques, thereby personalizing the therapeutic strategies. Current interest of most of the techniques for imaging atherosclerotic lesions is focused on providing either anatomic detail of plaque size and luminal narrowing, or quantifiable information regarding the cellular, biochemical, and molecular composition of plaques that may help determine plaque progression. Although noninvasive imaging and coronary angiography are still unable to identify plaque evolution and propensity for future instability, novel approaches, such as local WSS-dependent accumulation of inflammatory cells in specific vascular regions [3] has been derived by computational fluid dynamics (CFD) and mass transfer methods [4] . CFD methods based on in vivo 3-D vessel reconstructions have been introduced to assess the influence of WSS on plaque progression [5] , which can potentially furnish patient-specific fingerprints for risk stratification of a vascular lesion.
The heterogeneity of plaque distribution and progression, despite the exposure of the arterial vasculature to the same systemic risk factors, claims attention toward geometrical conditions and hemodynamic forces that may locally favor disturbed or low WSS [5] , [6] . Today, noninvasive techniques such as coronary computed tomography angiography (CTA) [7] or phase contrast magnetic resonance imaging [8] , [9] can reliably be employed for CFD evaluations. Gao et al. [10] managed to reconstruct carotid bifurcations including the lumen, the arterial wall, as well as the atheromatic plaque segments using magnetic resonance images, in order to identify the impact of the arterial geometry on the generated stresses of the artery. Tang et al. [11] created 3-D models of human carotid arteries, incorporating all types of atheromatic plaque so as to investigate critical flow conditions as well as the generated stress/strain values during those conditions and examine their correlation to plaque rupture. In another study of the same group [12] , 3-D multicomponent models of carotid bifurcations were created to examine the possible correlation of intraplaque hemorrhage and shear stresses. Sadat et al. [13] generated 3-D models of stenosed carotid arteries utilizing magnetic resonance images in order to acquire a biomechanical assessment of carotid plaques and investigate the connection between the timing of carotid plaque symptomatology and the maximum plaque stress concentration as it is calculated computationally. Finally, Steinman et al. [14] created 3-D models of carotid bifurcations from magnetic resonance images, allowing the precise measurement of the arterial wall thickness. However, modeling of atherosclerotic plaque growth and progression is usually based on measurements of local hemodynamics or geometrical features which do not account for "patient-specific" vulnerability, a clue for vascular lesion evolution.
In this study, a group of patients with coronary artery disease (CAD) and intermediate lesions was evaluated by CTA, and an innovative approach to simulate the WSS-related low density lipoprotein (LDL) transport across the endothelium and to identify LDL accumulation sites was used. The novelty of this study lies in the acquisition of systemic factors related to atherosclerosis evolution (risk profile, inflammation), measurements of coronary microcirculatory vasodilating capability, and the systematic verification of prediction of plaque progression by repeated CTA, six months after the baseline evaluation. Although preliminary, this study addresses the relevance of using innovative variables for modeling atherosclerosis, based on "patient specific" systemic and coronary local determinations, associated to CFD measurements and mass transfer methods.
II. MATERIALS AND METHODS
A. Patient Selection
Patients at intermediate risk for CAD admitted to CNR Clinical Physiology Institute-Fondazione Gabriele Monasterio of Pisa and in whom a coronary CTA demonstrated the presence of atherosclerosis lesions, confirmed by invasive coronary angiography, were enrolled. Also patients in whom potentially "vulnerable" coronary lesions were detected or had percutaneous coronary intervention with stent implantation were asked for participating to the study. In the enrolled patients, blood samples for determination of specific biomarkers linked to atherosclerotic process, were withdrawn at baseline and after six-month follow-up. Inclusion criteria were: patients with a clinical indication to CTA according to the guidelines, with documented CAD by CTA confirmed by coronary angiography; evidence of one or more non significant lesion; patient's informed consent. Exclusion criteria were: unstable clinical condition; heart failure or postischemic myocardial dysfunction (left ventricular ejection fraction <0.45); adverse reactions to contrast agents during the first coronary angiography; intolerance to adenosine administration; female with nonchildbearing potential. Pharmacological therapy and lifestyle were optimized in all patients immediately after knowledge of CTA results. Each patient was informed about the aim and risk of the procedures and signed a consent form before study entry. The study protocol was approved by the local Ethics Committee.
B. Clinical Protocol
Ten CAD patients fulfilling the inclusion/exclusion criteria entered the study. After enrolment, blood tests were repeated to measure plasma concentrations of LDL and of particles that affect the migration of monocytes and LDL in the arterial vessel wall, namely ICAM-1, VCAM-1, and E-selectin.
Following a follow-up of six months, a new clinical, biochemical, and morphological evaluation of coronary anatomy by CTA or coronary angiography (when clinically indicated) have been performed to check the progression of the coronary lesions. Therefore, CTA measurements at the enrollment aimed at predicting plaque progression by the proposed model, while CTA images at time six months were used to check the actual plaque progression towards the model prediction. Coronary CTA was performed for the diagnosis of CAD according to the international guidelines. A 64-slice scanner (Light Speed, General Electric HealthCare) was used. The procedure protocol consisted of a first standard scanning for calcium score computation (slice thickness 2.5 mm, prospective ECG gating, without contrast medium) and a second scanning during contrast medium infusion for coronary arteries visualization (slice thickness 0.625 mm, retrospective ECG gating). Tube voltage and current will be adapted in order to ensure the best image quality with an estimated cumulative radiation dose around 8-10 mSv. All the CTA examinations were performed using the same iodinated contrast agent (Iomeron 400, Bracco Diagnostics). Propranolol or metoprolol (1-5 mg I.V) was injected in order to reduce heart rate below 65 beats/min during examination. Sublingual or intravenous nitrates were used, when possible, to obtain coronary vasodilation and avoid the occurrence of coronary spasm. Row image datasets were reconstructed in multiple ECG phases with slice thickness of 0.6 mm with 0.2 mm of overlap using standard and sharper kernels.
Images were analyzed using a specialized software (CardiQ, Advantage Window 4.3; GEHC). Calcium score, an index of plaque burden, was computed with a standard method [15] . Volume rendering, multiplanar reformatting reconstruction, and vessel analysis were used for the evaluation of atherosclerotic lesions of major coronary vessels. Invasive coronary angiography was proposed to patients when CTA showed the presence of CAD with potentially vulnerable lesions or with significant coronary stenosis (≥50% lumen reduction). Coronary angiography was done by radial or femoral approach using six French disposable catheters. A flat panel system (Innova 2100, General Electric HealthCare) was used. Angiographic images (15 frames/s, 512 * 512 * 10 bit, standard DICOM format) were acquired with the patient in isocentric position in order to allow 3-D reconstruction of the selected coronary segments. Doppler flow measurements and intravascular ultrasound (IVUS) imaging were performed in segments previously selected by the CTA images. Not significant coronary lesions (diameter lumen reduction <50%) were the target lesions of this study. All segments reconstructed in 3-D from IVUS and 2-D coronary images were investigated by Doppler flow velocity technique, in order to provide patient-specific flow information of the segments evaluated by CFD analysis. Coronary flow reserve (CFR) and fractional flow reserve (FFR) were measured to assess the impact of stenosis on coronary vasodilating capability, as well as the potential relationship with plaque progression at follow-up. A coronary guide wire (0.014-in diameter) equipped with miniaturized tiptransducers for pressure and flow measurement (Combo wire, Volcano Corp.) was used. The guide was advanced into the coronary artery beyond the examined atherosclerotic lesion until a stable recording of pressure and flow velocity was obtained. Measurements were done at baseline and during maximal coronary vasodilation during intravenous adenosine administration (140 mcg/kg/min). CFR is defined as the ratio between maximum flow recorded during hyperemia and baseline flow, while the FFR is defined as the ratio between distal and proximal mean coronary pressure after adenosine. The IVUS study was performed to obtain detailed information of atherosclerotic plaques. A 3 French catheter with a 64-crystal electronic ultrasound probe was used (Eagle-Eye, Volcano Corp.). The catheter was advanced in the distal part of the vessel beyond the examined lesion and then, a mechanized pullback at the rate of 1 mm/s was performed. Two isocentric angiographic views were filmed for tracing the initial pullback position of the catheter inside the coronary vessel. The spatial resolution of this technique is around 100 μm and the temporal resolution is about 10 images/s. IVUS extends the angiographic exam of about 10 min and does not need any additional contrast agent administration. No adverse events caused by IVUS were observed in our study population. Invasive coronary angiography and IVUS findings were used to confirm the degree of the lesions and the plaque components, as detected by CTA.
C. Coronary Tree Extraction and Visualization From CTA
The first step of the proposed method is to select the region of interest which comprises the region of the heart including the desired coronary arterial tree. In this region, components such as the pulmonary arteries and aorta also exist. The acquired images are converted to binary by replacing all pixels with brightness greater than a specified limit with the value one (white), and all other pixels with the value zero (black). The specified limit is an image adaptive threshold limit = k × max(I(i, j)), where k is found heuristically to be 0.6. Then, object filtering is performed in order to exclude the objects which do not represent the coronary arteries. The size of the objects in a typical 280 × 310 heart area binary image varies from 10 to 2000. Since arteries exhibit sizes between 100 and 700 pixels, we can safely discard objects with size below 50 and above 900 pixels. After this step, a new 3-D volume stack of binary images is created.
In the next step, the coronary arteries are identified in the images. The medical expert provides two seed points, one for the LCA and one for the RCA, and two 3-D data cubes are created. The identification is achieved by identifying which voxels are connected and assigning the same label on them. Label equivalences are recorded using the 26-connected neighborhood connectivity. In this scheme, two "on" voxels are considered connected if the following condition is valid: two voxels share either one common face (6 options) or one common edge (12 options) or one common corner (8 options). Label equivalences are recorded in a union find table and equivalence classes are resolved using the union-find algorithm [16] . The output is a new 3-D data cube, within which the two coronary arteries are labeled and their segmentation is straightforward.
In the next step, the branches in the 3-D volume are separated. The separation consists of three main steps: ramification detection, single-branch data cubes creation, and cubes refinement. Let I be the 3-D data cube containing the image data of a coronary artery and I k the kth frame of it. All objects in I k are labeled and counted. Let l be the total number of frames and num(k) be the number of objects in the kth frame, with num(l) = 1. Assuming that the first ramification occurs in frame i, then in that frame two objects are detected and num(i) = 2. In general, wherever a ramification occurs in pth frame, then num(p -1) = n and num(p) = n + 1. On the other hand, when an arterial branch ends, the number of the identified objects is reduced. Let q be the first frame in which a certain branch is not visible, then num(q -1) = m and num(q) = m -1. Based on the above, the initial data cube I is divided in sectors within which no alterations in the quantity num are observed.
Then, the single-branch data cubes algorithm creates a set of data cubes including only one branch and labeling appropriately. Then, data fusion is performed between the data from these data cubes and the original grayscale 3-D image dataset. In particular, every frame of each cube created from the previous step includes only one object. A thinning algorithm is implemented by calculating the centre of mass for each object yielding to thinned 3-D arterial tree which constitutes the arterial centerline.
The center of mass coordinates are used as the initial active contour's middle point in a snake deformation [17] over the corresponding grayscale frame of the original dataset. More specifically, let α(s) = [x(s), y(s)], s ∈ [0, 1] be a curve which has the property to deform according to the energy function E active , trying to minimize it. E active is defined as
where
is the internal energy function, E image is an energy function which depends on the image's properties, and k(s) and λ(s) are regularization terms. For the calculation of the internal energy function E image , the gradient vector flow (GVF) method [18] is used. This method determines the GVF to be the field
that minimizes the energy function:
Finally, from each single branch data cube, a point cloud, which consists of a set of nodes, eight for each frame, between two pairs of lines drawn on planes, is extracted. Consequently, the method demands degeneration of the 3-D problem into four 2-D problems. This is done by assuming four orthogonal projections of the 3-D space with azimuth angle φ = {0, 45, 90, 135} and considering the projections of both the centerline and the data cube on them. For example, in the case of xz plane (x = 90 • ), axial CT images would provide the correct borders of the artery only if the latter was oriented parallel to the vertical (z) axis. Since, in general, this is not the case, it is essential to estimate the direction of the artery. Specifically, the artery centerline and the data cube are projected in the xz plane and N + 2 lines are drawn, where N is the number of frames. The N lines are perpendicular to the centerline curve for every frame, and the other two are the borders of the artery in the xz plane. The nodes of every perpendicular line with the borders (2N points in total) are the correct initialization points for the artery reconstruction.
In the next step, the normal to centerline lines are extracted. For every frame of the 3-D data cube, the centre of mass coordinates {x c (z), y c (z)} are defined as previously described, forming a 3-D centerline. Let C x = x c (z) be the projection of the centerline in the {xz} plane. To estimate the inclination of C x , we consider the gradient ∂x/∂z. When (∂x/∂z) → 0, the direction of the artery is vertical and the tangent of C x is parallel to the z-axis. When (∂x/∂z) → ∞, the direction of the artery is horizontal and the tangent is normal to the z-axis. Knowing the direction of the tangent of C x for every z, it is straightforward to define the direction of the normal for the same points. More specifically, if
is the equation which describes the tangent, then
where b ⊥ is the equation which describes the normal with
is extracted from the data for every frame as
In the next step, the projected border lines are extracted. More specifically, the projection of the 3-D data cube in the {xz} plane yields a 2-D point cloud. From the latter, we trace for every frame (z = constant) two values {min x(z), maxx(z)} which are the minimum and maximum values of x in that frame. Two 2-D curves are created: C minx = minx(z) and C max x = max x(z). Interpolation is performed to obtain near continuous editions of C x and C max x . Finally, the two nodes between C normal and C min x , C max x , respectively, are the two out of the eight points to be extracted as output for every frame of the data cube. Since these two points belong to the {xz} plane, they are embedded in the 3-D space by assigning to them as a y-coordinate, the value y c from the corresponding frame. The six remaining points are the result of the application of the same procedure in the other three projection planes. Finally, the nodes for the whole dataset are produced, by applying the methodology for all data cubes I rsb , for both LCA and RCA. Fig. 1 presents two examples of the output of the 3-D reconstruction algorithm.
D. Plaque Characterization
The algorithm for plaque characterization is designed in a way that permits a fully automated identification and segmentation of calcified plaque lesions in coronary arteries. The input to the algorithm is standard CTA axial scans. In addition, the algorithm requires as input the borders of the artery, which are obtained as described in Section II-C. The method consists of two major steps. The first is the identification of possible calcified regions in all the CTA image frames. This is achieved based on the assumption that calcifications exhibit a significantly larger intensity value in comparison with the other plaque components. The second step consists of the segmentation of calcified plaque lesions on the CTA frames for which the identification subroutine returned a positive result. It uses the fuzzy c-means clustering method. Finally, the percentage of the artery inner wall area that is calcified is calculated.
1) Calcification Identification:
In the first step, the existence of calcified regions on each CTA image frame is examined. Let I(s) be the intensity values with s ∈ A, A, is the artery region. For each image frame, we calculate the quantity as
We assume that a calcification exists if and only if x ≥ b, where b is a constant. Based on previous studies [19] , [20] and on our experiments, we set b = 0.55. This means that our method identifies a calcification in the frames where the maximum intensity value within the artery region is at least 55% larger than the minimum one. 2) Calcification Segmentation: Once calcified plaque lesions are identified in a particular CTA image frame, we proceed with the segmentation of the calcified region. For this purpose, we take advantage of the calcium hyperintensity in the CTA images. Again, we consider the intensity of the pixels within the artery region. Then, we perform fuzzy c-means clustering on these data. Calcium's hyperintensity in contrast with the darker and relatively uniform other artery regions leads to the demarcation of the data into two clusters. Pixels belonging to the cluster that contains the pixels with the higher intensity values are considered to represent calcified regions of the artery inner wall. Finally, a quantitative estimation of the calcification of the artery is performed. The calculation is quite straightforward, considering that the segmentation has been performed.
To better characterize the plaque components in the investigated segments, IVUS analysis with virtual histology was applied [21] . IVUS virtual histology allow for recognition of four components of atherosclerotic plaque that are represented with different colors: fibrous plaque (green), fibro-fatty plaque (yellow), calcified necrotic plaque (red), and calcified plaque (white) (see Fig. 2 ). The reliability of data obtained with this approach has been tested in vitro; the principal limitation is the low resolution (about 300 μm). Despite this limitation, IVUS virtual histology is at present the most useful reliable technique for in vivo analysis of coronary plaque burden.
E. Blood Flow Modeling
The blood flow in the lumen domain is modeled by the Navier-Stokes equations, together with the continuity equation for incompressible fluids:
where l refers to the lumen, u l is the blood velocity, p l is the lumen pressure, μ is the dynamic viscosity of blood, and ρ is the blood density [22] . Blood velocity and pressure are taken from the patient-specific measurements. Mass transfer in the blood lumen is coupled with the blood flow and is modeled by the convection-diffusion equation:
in the fluid domain, where c l is the solute concentration in the blood lumen and D l is the solute diffusivity in the lumen.
In addition to the velocity field, the WSS computation is performed. The mean shear stress τ mean within a time interval T is calculated as [23] 
where t s is the surface traction vector. Another scalar quantity is a time-averaged magnitude of the surface traction vector, calculated as
The oscillatory shear index is (OSI) defined as [24]
F. Mass Transfer Modeling
Mass transfer in the arterial wall is coupled to the transmural flow and modeled by a convection-diffusion-reaction equation as follows:
where c w is the solute concentration and D w is the solute diffusivity in the arterial wall; u w is the blood velocity in the wall, K is the solute lag coefficient, and r w is the consumption rate constant. The mass transport in the lumen and in the vessel wall is coupled by the Kedem-Katchalsky equations [25] : (18) where L p is the hydraulic conductivity of the endothelium, Δc is the solute concentration difference, Δp is the pressure drop, and Δπ is the oncotic pressure difference, in the endothelium, σ d is the osmotic reflection coefficient, σ f is the solvent reflection coefficient, P is the solute endothelial permeability, andc is the mean endothelial concentration. The first term in the KedemKatchalsky equations PΔc of the right-hand side in (18) defines the diffusive flux across the endothelium, while the second term (1 − σ f ) J vc defines the convective flux. Only the oncotic pressure difference Δπ is neglected in our simulations because of the decoupling the fluid dynamics from the solute dynamics.
The aforementioned governing equations are transformed into an FE system of incremental-iterative equations and solved over time steps.
The atherosclerotic process starts with the accumulation of LDL in the intima, where part of it is oxidized and becomes pathological. In order to remove the oxidized particles, circulating immune cells (e.g., monocytes) are recruited. Once in the intima, the monocytes differentiate and become macrophages that phagocyte the oxidized LDL. Fatty macrophages then transform into foam cells. Foam cells are responsible for the growth of a subendothelial plaque which eventually emerges to the artery lumen. The inflammatory process is modeled using three additional reaction-diffusion partial differential equations [26] :
where O is the oxidized LDL in the wall; M and S are concentrations in the intima of macrophages and cytokines, respectively; d 1 , d 2 , and d 3 are the corresponding diffusion coefficients; λ and γ are the degradation and LDL oxidized detection coefficients; and v w is the inflammatory velocity of plaque growth, which satisfies Darcy's law and the incompressibility continuity equation [27] :
in the wall domain. Here, p w is the pressure in the arterial wall. In order to follow the change of the vessel wall geometry during plaque growth, a 3-D mesh moving algorithm Arbitrary Lagrangian-Eulerian (ALE) is employed [28] . While pulsatile blood flow simulation has much smaller time scale than wall plaque progression, we have taken into account these changes through the same time resolution for geometry change for both lumen and wall domains. The change in the wall volume has direct influence on the lumen volume change and feedback on the WSS distribution.
For plaque volume progression, we need at least two different points in time from medical images. We use the following equations:
where F t n ( k + 1 ) (i, j) is a function of the coordinate or wall thickness I for cross section j at time t n ; k is iteration, k = 0,1,2,3. . .; n is the time point for image data; p(0), p(1),. . . are coefficients; τ wss is the WSS; and Δt is time step. A simple linear regression analysis with least squares method is used for the estimation of the coefficient p(0), p (1) . . . for each specific patient.
A fitting procedure [29] for growth function from baseline to follow-up which takes into account change of the coordinates and WSS has been developed. The aforementioned equations are connected with hemodynamics from (10)-(15) in order to determine WSS, mass transfer from (16)- (18) to calculate the amount of LDL that is transferred from lumen to wall domain, biological reaction (19) to calculate the macrophages, the oxidized LDL, the cytokines and the foam cells that are produced, and (22) to fit volume change from medical images and to make the coupling between measurements clinical and simulation data. From the clinical data, we used the medical images from CT (baseline and follow-up), IVUS from baseline, boundary conditions for flow and pressure (baseline), and virtual histology (IVUS) for plaque composition at baseline. The plaque composition at follow-up is provided from computer simulation, using boundary conditions from the baseline. Both volume progression and plaque composition are simulated, while volume progression is fitted from CT medical images at follow-up.
G. Clinical Validation by CTA Follow-Up
CTA images were acquired at six-month follow-up by using the same acquisition parameters at baseline and collecting data at a similar patient's heart rate. The 3-D artery reconstruction and plaque characterization were accomplished by using the baseline reconstructed images as mask, in order to obtain superimposable vessel pathway (see Figs. 3 and 4) . Quantitative image analysis and plaque characterization were undertaken by two independent expert cardio radiologists, unaware of the clinical features. Discrepancies in measurements were solved by a third observer. IVUS analysis and multiple views coronary angiography were utilized as gold standard for plaque characterization and diameter lumen measurements, respectively. Plaques were defined as noncalcified, calcified, or mixed. A lesion progression at six-month follow-up was defined when the lumen diameter decreased of at least 30% from baseline.
III. RESULTS
A. Patient Characteristics
Patient demographic and clinical characteristics, including risk factors and Framingham score, in the ten enrolled patients are reported in Table I . Most of the patients had high Framingham risk score, but not significant coronary lesions at coronary angiography. Therefore, the target population was characterized by patients with risk factors and non obstructive coronary plaques in CTA and IVUS studies.
B. Plaque Characterization and Detection of Lesion Progression
Four of the ten enrolled patients completed the six-month follow-up by CTA, following the baseline evaluation (patients 1, 3, 4, 5). CTA allowed a complete evaluation of the three main coronary arteries, with high-quality visualization of vessel geometry and pathway, and definition of plaque characteristics. At baseline, IVUS and 2-D coronary angiography permitted to confirm the presence of target lesions in all patients, with further details on plaque composition. Two of the four patients (patients 3 and 5) showed an obvious reduction of lumen diameter, indicative of plaque progression, both in the distal portion of the circumflex artery. Plaque was defined mixed in one patient and noncalcific in the other, according to CTA and IVUS (virtual histology) criteria. Plaque progression occurred in a bend region of the vessel and in its inner part in both patients. CFR was within the normal range (>3) in all investigated segments but one (CFR 2.5), corresponding to the circumflex artery with plaque progression (patient 3). FFR was within the normal values (>0.92) in all investigated segments but one (FFR 0.89) located in the circumflex artery with the most obvious plaque progression (patient 5). Thus, two segments with plaque growth at six-month follow-up in patients 3 and 5 were characterized by impaired CFR or reduced FFR, respectively. Angiographic and hemodynamic features at baseline and at six months in the four patients are depicted in Table II . Plaque composition in the six segments evaluated by IVUS and virtual histology is reported in Table III . Imaging and Doppler flow velocity data in the two patients with plaque progression are shown in Figs. 3 and 4 .
C. WSS and Mass Transport Computation
Plaque progression for patient 3 at distal circumflex artery region was assessed by comparing CTA images at baseline and after six months. Volume progression from 35% to 48% was observed with segmentation and registration of CT images. Downstream the bifurcation level with the second marginal branch, predominantly low WSS values occurred at baseline (see Fig. 5(a), arrow) . A similiar situation with a more obviously demonstration of the influence of WSS was observed for patient 5 in the distal portion of the circumflex artery (see Fig. 6 ), which showed a marked progression of the baseline stenosis. Location of the lowest WSS [see Fig. 6(a) ] in the distal portion of the vessel corresponded to the site of plaque growth after six months [see Fig. 6(b) ]. WSS distributions on the proximal left anterior descending artery at baseline and follow-up for patient 3 are shown in Fig. 7 . It can be seen that intraplaque WSS values were not reduced, as compared with the surrounding segments, and no significant change was observed with time, according to no change in plaque volume progression.
CFD data were used as input for a fitting procedure of volume plaque progression. Oxidized LDL distribution at baseline and follow-up study after six months in patient 5 is shown in Fig. 8 . It can be observed that after six months, there is a significant increase in LDL distribution distal from the most narrowed part of the lumen domain. Due to complex lumen and wall domain, only LDL distribution for the joint boundaries is presented in Fig. 8 . WSS in our model is used for plaque initiation and position at the wall for higher LDL penetration. There is a complex process of the macrophages transformation into the foam cells which is described in (17)- (19) . Also, foam cells directly created the intima volume increase which is described in (20) and (21) . Fitting of the plaque volume increasing of 34% from baseline to six-month follow-up observed from medical image analysis was done with (22) . The parameters for the numerical models of patient 5 are given in Table IV .
D. Features Affecting Plaque Progression
Although preliminary, the findings from ARTreat study point the attention on specific features that may affect plaque progression in a short-mid term (six months). Plaque progression occurred in two patients with the highest Framingham risk score (25 and 23) of the enrolled population, both plaques developed at the inner side of curved (myocardial side) distal circumflex artery segments. Interestingly, only these territories showed an impaired CFR or reduced FFR, indicative of an impaired coronary vasodilating capability. The greatest plaque growth occurred in a non calcified, eccentric plaque (patient 5). At virtual histology (IVUS study), the fibro-fatty component was the prevalent content of this plaque, markedly higher than that observed in the other patients (see Table III ). Conversely, necrotic core was the scarce component. Patient 5 showed the highest increase in E-Selectin plasma concentrations, at six-month evaluation, largely above the normal range, among the four patients that completed the study, while only patient 4 showed an obvious increase in VCAM-1. No changes were observed in ICAM-1 levels in the four patients. Baseline WSS values in the progressive lesions (patients 3 and 5) were 3.36 dyne/cm 2 and 1.85 dyne/cm 2 , respectively. These values were lower than those calculated immediately before and after the lesions. Conversely, WSS values in the four stable plaques averaged 4.2 ± 0.4 dyne/cm 2 and were not lower than values calculated in segments immediately adjacent to the stenoses.
IV. DISCUSSION
CTA is clinically used to improve the management of patients with suspected ischemic heart disease, and the newest technology (64 slice CT or 256-slice multidetector CT and dual source instruments) has greatly improved spatial and temporal resolution, allowing better details of coronary morphology and improvement of imaging accuracy in detection of coronary lesion severity. However, conventional coronary CTA does not provide functional information on the hemodynamic relevance of a plaque and, mainly, the capability to predict plaque formation and progression. Realistic anatomic models allow CFD analysis to evaluate the local distribution of velocity, WSS magnitude, and gradients (temporal and spatial) as well as understanding regions of disturbed flow [30] . Furthermore, when models for transmural mass transport and vessel wall changes during plaque growth are applied [5] , [13] , sites of plaque formation and progression can be predicted, contributing to the definition of the functional meaning of a nonlimiting flow atherosclerotic lesion.
A multiscale model for the biological process of plaque formation and progression has been applied to CTA imaging in patients with nonobstructive coronary plaques. The model includes the 3-D reconstructed arterial model, the blood flow, the WSS distribution, the molecular/cell model of the arterial wall/blood composition, and the biological mechanism involved in the generation and growth of atherosclerotic plaque. The governing partial differential equations for plaque formation rely on the mass balance and Darcy's law in the domain of plaque development; the Navier-Stokes equations and diffusion equations are used for the LDL transport within the arterial lumen; the transport-diffusion-reaction equations are employed for the transmural mass transport, including the Kedem-Katchalsky equations to couple the transmural and transport within the lumen. The wall permeability was assumed to be a function of the WSS with lower permeability at low and oscillatory shear stress. We describe the inflammatory process using reaction-diffusion equations. Our model starts with passive penetration of LDL in particular areas of the intima. We assume that once in the intima, LDL is immediately oxidized. When the oxidized LDL exceeds a threshold, there is recruitment of monocytes. The incoming monocytes immediately differentiate into macrophages. Transformation of macrophages into foam cells contribute to the recruitment of new monocytes. This yields the secretion of a proinflammatory signal (cytokines), self-support inflammatory reaction. Newly formed foam cells are responsible for the local volume increase. To our knowledge, there is no similar approach on the cell level like the one we proposed. The main novelty of this study relies on the coupling between the reaction diffusion equations with plaque composition and the hemodynamic through the shear stress exerted by the blood flow on the arterial wall. Under a local incompressibility assumption, when foam cells are created, the intima volume is locally increasing. Volume change of the wall affects the fluid lumen domain which means that fully coupling is achieved. The specific numerical procedures using ALE with the same time resolution for plaque progression and mesh moving were developed for this purpose. The change of the wall volume during plaque progression has a direct influence on the lumen domain and shear stress distribution. The regression analysis was employed for plaque volume development at two different measurement times for baseline and six-month follow-up study. Nonlinear least squares fitting procedure was used for the plaque composition at the baseline using IVUS images. Our model gives a computer prediction of plaque composition for six-month follow-up.
A. Functional Approach to Plaque Formation From Coronary CTA Scan
Although preliminary, the presented data support the usefulness of CFD and mass transfer approach to 3-D reconstructed coronary CTA scans in the evaluation of atherosclerotic plaque burden, potentially shifting the clinical information of coronary CTA from morphological assessment toward a functional tool. The worth of this study, still in progress, is the collection of several features (clinical, biological, anatomical, and functional) known to be related to coronary plaque formation and progression, which will be tested as predictor of plaque evolution. Increments of circulating adhesion molecules and impaired CFR, features not included in plaque models reported in the literature, seem interesting features accompanying plaque progression. The study is preliminary and after obtaining results from the additional patient studies, the proposed method has to be evaluated in the clinical setting in order to prove its usefulness.
In a recent observational study in 1103 subjects (207 with diabetes), assessment of CFR provided additional prognostic information in those subjects with suspected CAD despite negative dipyridamole stress echocardiography. An abnormal CFR (≤2) was shown to be an independent prognostic indicator of cardiovascular risk [31] . Thus, it is conceivable that coronary vasodilating capability is affecting local WSS values during the daily activity, and that its impact in plaque formation and progression could be much more relevant than baseline flows, usually employed in calculation of WSS by CFD. Furthermore, the altered flow condition (like FFR) during plaque growth may modify the plaque progression patterns, since the altered flow field modulates the flow-dependent shear stress and it, in turn, modulates the plaque progression. Knowledge of the FFR at follow-up (not measured in this study), once the vessel geometry has been updated by the growing plaque, would further clarify the relation between pressure-flow drop and the pattern of disease progression.
The coronary microcirculatory response to vasodilators should be included among the boundary conditions, expanding the Navier-Stokes principle. The role of each feature and the best combination of features (systemic and local) predicting plaque formation or changes with time can be ascertained by large-scale clinical studies powered to statistically identify parameters linked to atherosclerotic plaque evolution. CTA scan is an imaging modality suitable for identification of features associated with plaque progression, due to its noninvasive nature and its ability to explore the whole coronary tree.
B. Personalized Approach to Prediction of Coronary Plaque Progression
In this study, a personalized approach to prediction of coronary plaque progression has been employed and the preliminary results have been presented. Besides the low values of local WSS observed in areas which showed increases in plaque volumes at follow-up CTA, patients' risk profile, pattern of circulating adhesion molecules, plaque characteristics, and reduced FFR or CFR observed at baseline appeared to affect plaque progression toward flow-limiting lesions at follow-up evaluation.
Studies of plaque localization in the human carotid bifurcation have shown that regions of low or oscillatory flow velocity and WSS are prone to develop atherosclerotic lesions, whereas areas of high shear stress are spared [32] . The left coronary artery bifurcation into left anterior descending and circumflex branches has a particular predilection for plaque formation, while the prevalent location of plaque formation in bend segments is still debated. Jeremias et al. in an IVUS clinical study found that plaques develop more frequently to the inner side (myocardial side) of the vessel wall [33] . The authors suggested that these sites are prone to low WSS, in which flow separation, flow reversal, turbulence, and eddying occur, although computation of local WSS was not attained. The two time points obtained in our study population allowed us to characterize the native shear stress in the two vessels site of plaque progression with time. In fact, the baseline sub significant lesions in distal circumflex artery (lumen diameter reduction of 35% and 33%) subtended to low WSS values that markedly changed in patient (case 5) with plaque progression toward an almost critical stenosis. Most of the fitting parameters, namely intracoronary flow velocity and pressures, were obtained from patient-specific measurements at the time of catheterization procedure (usually 1-2 weeks following CTA evaluation). Furthermore, plaque composition was assessed by virtual histology in each patient, providing a degree of accuracy higher than CTA, that will allow better definition of models for plaque progression. The applied methodology is also improving the reliability of WSS computation and interpatient comparison. We are aware that this "hybrid" approach (CTA imaging and intravascular studies) cannot be applied in the clinical setting; however, we used accurate information on plaque composition, FFR and CFR measurements by the invasive techniques to better tune the modeling approach. It should be mentioned that the invasive measurements (like IVUS, FFR, and 2-D Angiography) are used in the current phase of the models and techniques development. After the final parameterization and final definition of the models, only a CTA scan of the patient during his examination will be needed in order to run the models and predict plaque progression.
Very recently, Koo et al. [34] have introduced a noninvasive FFR measurement derived from CTA as novel method with good diagnostic performance for the detection and exclusion of coronary lesions that cause ischemia. This approach, together with an improved characterization of plaque composition by CTA, will better permit to investigate determinants of plaque progression by noninvasive techniques. Future development of fully noninvasive approaches, either by CTA (FFR) or by positron emission tomography [35] will provide dynamic measurements useful for more appropriate models of plaque growth. Further support to reliability of CTA image reconstruction and shear stress measurement will be derived from investigations under way on comparison of WSS measurements by 3-D segment reconstruction from IVUS and angiography. The heterogeneous course of each plaque in the same patient underscores the role of vessel geometry and local hemodynamic forces in determining the natural history of plaque remodeling. Patient-specific local and systemic features, as assessed in this study, can provide insights on the nature of arterial remodeling and, potentially, on plaque vulnerability [36] .
C. Method Limitations
Our "hybrid" approach cannot be proposed in the clinical arena, mainly in low-moderate risk patients; nevertheless, the use of IVUS and flow Doppler information permits to reduce errors related to CTA evaluation alone and to gain better characterization of plaque composition and accurate flow measurements at baseline.
Conversely, invasive measurements of CFR and FFR at sixmonth follow-up, not performed in this study, would have better defined the modulation of flow on plaque progression patterns; however, this evaluation raises ethical issues on radiation exposure and invasiveness of the study.
Smooth muscle cells proliferation was not taken into account in this model and will be investigated in a future study. Moreover, we have not taken into account deformation and stress inside the arterial wall which is very important for the plaque rupture and smooth muscle proliferation for plaque growing. Arterial wall was assumed to be rigid and fluid-structure interaction was not implemented.
V. CONCLUSION
A patient-specific 3-D model for plaque development, coupled with blood flow and LDL concentration in blood, was created from coronary CTA scans and quantitative information achieved by intravascular flow and IVUS study. The model is based on partial differential equations with space and times variables and it describes the biomolecular process that takes place in the intima during the initiation and the progression of the plaque. Plaque components of the wall measured from the medical images and impairment of coronary vasodilating capability seem to impact on plaque evolution and should be included in the model. We have taken into account foam cells growing, macrophages, and cytokines distribution. Moreover, plaque progression is considered through continuum modeling approach but with a clear microlevel cell proliferation modeling. It is a full continuum approach without discrete modeling on the cell level, which will be the issue of our future research. Also, quantification of the real patient-specific plaque progression has been investigated, providing the end-point for assessment of the model under development.
Determination of plaque location and composition, and computer simulation of progression in time for a specific patient shows a potential benefit for the prediction of disease progression. The proof of validity of 3-D reconstructed coronary CTA scans in the evaluation of atherosclerotic plaque burden may shift the clinical information of coronary CTA from morphological assessment toward a functional tool.
